about
Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.A quantitative and kinetic fusion protein-triggering assay can discern distinct steps in the nipah virus membrane fusion cascadeSARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current status of anti-SARS agents.
@ast
Current status of anti-SARS agents.
@en
type
label
Current status of anti-SARS agents.
@ast
Current status of anti-SARS agents.
@en
prefLabel
Current status of anti-SARS agents.
@ast
Current status of anti-SARS agents.
@en
P2860
P1476
Current status of anti-SARS agents.
@en
P2093
Shiro Shigeta
Toshihiro Yamase
P2860
P356
10.1177/095632020501600103
P577
2005-01-01T00:00:00Z